Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat
- 1 September 2000
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 74 (1-2) , 45-56
- https://doi.org/10.1016/s0960-0760(00)00087-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal WomenNew England Journal of Medicine, 1995
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal WomenAnnals of Internal Medicine, 1991
- Evaluating the benefits and risks of postmenopausal hormone therapyThe American Journal of Medicine, 1991
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Determinants of bone density in normal women: risk factors for future osteoporosis?BMJ, 1989
- Estrogen Replacement Therapy: Indications and ComplicationsAnnals of Internal Medicine, 1983
- Menopause and Coronary Heart DiseaseAnnals of Internal Medicine, 1978
- Association of Exogenous Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1975